logo

For the Inventor, By the Inventor

Vedb k, Denmark

Lars J Knutsen

USPTO Granted Patents = 12

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Bagsvaerd, DK (1993)
  • Vedbaek, DK (1991 - 1994)
  • Vedb k, DK (1993 - 1996)
  • Vedb.ae butted.k, DK (1996 - 1997)

Company Filing History:

goldMedal12 out of 1,777 
 
Novo Nordisk A/s
 patents

Years Active: 1991-1997

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5683989 - Treatment of ischemias by administration of 2,N.sup.6 -substituted (1997-11-04),
2. 5672588 - Purine derivatives (1997-09-30),
3. 5589467 - 2,5',N6-trisubstituted adenosine derivatives (1996-12-31),
4. 5578582 - Methods of treating ischemia with C2, N.sup.6 -disubstituted adenosine (1996-11-26),
5. 5484774 - 2, N.sup.6 -disubstituted adenosines, tri-O-ester derivatives and their (1996-01-16),
6. 5432164 - C2,N.sup.6 -disubstituted adenosine derivatives (1995-07-11),
7. 5430027 - 2-chloro-N.sup.6 -substituted adenosines, their pharmaceutical (1995-07-04),
8. 5348965 - N-substituted azaheterocyclic carboxylic acids (1994-09-20),
9. 5231106 - Azacyclic carboxylic acid derivatives and their preparation and use (1993-07-27),
10. 5229404 - Azacyclic carboxylic acid derivatives and their preparation and use (1993-07-20),
11. 5214054 - Azacyclic carboxylic acid derivatives and their preparation and use (1993-05-25),
12. 5039685 - Azacyclic carboxylic acid derivatives, their preparation and use (1991-08-13),

Title: **Lars J Knutsen: Innovator in Pharmaceutical Development**

Introduction

Lars J Knutsen is a distinguished inventor based in Vedbæk, Denmark, recognized for his valuable contributions to the field of pharmaceuticals. With a remarkable portfolio of 12 patents, Lars continues to play a pivotal role in advancing medical treatments through innovation.

Latest Patents

Among his latest patents is a groundbreaking treatment for ischemias achieved through the administration of 2,N.sup.6 -substituted compounds. This invention relates to compounds of a specific formula, which have the potential to offer significant therapeutic benefits. Another notable patent involves purine derivatives, which include a compound of a defined formula or its pharmaceutically acceptable salts, thereby broadening the scope of potential treatments available.

Career Highlights

Lars works with Novo Nordisk A/S, a leading global healthcare company known for its innovative solutions in diabetes care and other chronic diseases. Throughout his career, he has dedicated himself to researching and developing novel treatments that can transform patient outcomes and enhance therapeutic options.

Collaborations

Collaboration is a key aspect of Lars’ work, and he has had the privilege of working alongside esteemed colleagues such as Jesper F Lau and Knud Erik Andersen. This teamwork underscores the importance of diverse expertise in the successful development of innovative solutions within the pharmaceutical industry.

Conclusion

In conclusion, Lars J Knutsen's contributions to the field of pharmaceuticals highlight his innovative spirit and commitment to improving healthcare. His latest patents showcase his dedication to advancing medical science, providing hope for better treatments and patient care in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…